OIP5 and pancreatic neoplasm: Furthermore, survival analysis showed that pancreatic cancer patients with high expression of OIP5-AS1 and NGFR had low survival rates, while patients with low expression of miR-186-5p had a lower survival rate (Figure 4I–4K).